Translation of remote ischaemic preconditioning into clinical practice.
Reduction of the burden of ischaemia-reperfusion injury is the aim of most treatments for cardiovascular and cerebrovascular disease. Although many strategies have proven benefit in the experimental arena, few have translated to clinical practice. Scientific and practical reasons might explain this...
Main Authors: | Kharbanda, R, Nielsen, T, Redington, A |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2009
|
相似書籍
-
BETA-CATENIN PATHWAY EXPRESSION IN HUMAN MYOCARDIUM IS INCREASED BY A REMOTE ISCHAEMIC PRECONDITIONING STIMULUS
由: Contractor, H, et al.
出版: (2009) -
Increased Beta-Catenin Pathway Expression by a Remote Ischaemic Preconditioning Stimulus: First Evidence in Humans
由: Contractor, H, et al.
出版: (2009) -
ADENOSINE RECEPTOR INHIBITION ABOLISHES REMOTE ISCHAEMIC PRECONDITIONING IN HUMANS
由: Contractor, H, et al.
出版: (2009) -
Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study.
由: Kharbanda, R, et al.
出版: (2006) -
Remote ischaemic preconditioning (rIPC) reduces cardiac and pulmonary dysfunction following experimental cardiopulmonary bypass
由: Kharbanda, R, et al.
出版: (2004)